Helix Fund logo

Helix Fund

North America, Illinois, United States, Chicago

Description

Helix Fund is a real estate investment management company based in Chicago, United States.

Investor Profile

Helix Fund has made 7 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (43%)
  • Series Unknown (29%)
  • Post Ipo Equity (14%)
  • Seed (14%)

Country Focus

  • United States (86%)
  • Hong Kong (14%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical Device
  • Apps
  • Blockchain
  • Casual Games
  • Developer Platform
  • Metaverse
  • Video Games
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Helix Fund frequently co-invest with?

Hashed
North America, California, United States, San Francisco
Co-Investments: 1
St. Louis Arch Angels
North America, Missouri, United States, St Louis
Co-Investments: 2
MT
North America, Missouri, United States, Jefferson City
Co-Investments: 4
Cultivation Capital
North America, Missouri, United States, St Louis
Co-Investments: 3
ABC Laboratories
North America, Maryland, United States, Columbia
Co-Investments: 2
Mind Fund
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
BioGenerator
North America, Missouri, United States, St Louis
Co-Investments: 6
Bolloré Group
Europe, Ile-de-France, France, Puteaux
Co-Investments: 1
True Global Ventures (TGV)
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
ThunderCore
North America, California, United States, Sunnyvale
Co-Investments: 1

Which angels does Helix Fund often collaborate with?

AB
Europe, Stockholms Lan, Sweden, Stockholm
Shared Deals: 1

What are some of recent deals done by Helix Fund?

Animoca Brands

Cyberport, Hong Kong Island, Hong Kong

Animoca Brands is a metaverse and gaming company focused on driving digital property rights through NFTs.

AppsBlockchainCasual GamesDeveloper PlatformMetaverseVideo Games
Post Ipo EquityMay 22, 2019
Amount Raised: $2,500,000
Euclises Pharmaceuticals

St Louis, Missouri, United States

Euclises Pharmaceuticals develops novel COX-2 inhibitors for the effective treatment of cancers in the lungs, colon, and pancreas.

BiotechnologyHealth CarePharmaceutical
Series UnknownSep 23, 2015
Amount Raised: $2,000,000
Covercress

St Louis, Missouri, United States

Covercress is a biotechnology company that manufactures an oilseed crop for food, bioenergy, and cattle feed.

Animal FeedBiotechnologyFuelIndustrialNutritionOil and GasRenewable Energy
Series AMay 11, 2015
Amount Raised: $2,500,000
SynerZ Medical

St Louis, Missouri, United States

SynerZ Medical is a medical device company providing treatment for obesity and type 2 diabetes.

BiotechnologyDiabetesHealth CareMedical Device
SeedFeb 24, 2015
Amount Raised: $650,000
Euclises Pharmaceuticals

St Louis, Missouri, United States

Euclises Pharmaceuticals develops novel COX-2 inhibitors for the effective treatment of cancers in the lungs, colon, and pancreas.

BiotechnologyHealth CarePharmaceutical
Series ASep 9, 2014
Amount Raised: $1,300,000
MediBeacon

St Louis, Missouri, United States

MediBeacon is an optical diagnostic company providing clinicians with critical information that improve patient care.

BiotechnologyHealth CareMedical DeviceReal Time
Series UnknownMar 18, 2013
Confluence Life Sciences

St Louis, Missouri, United States

Confluence Life Sciences is focused on rational drug designs to develop novel kinase inhibitors for use in human and animal healthcare.

BiotechnologyHealth CareLife ScienceMedical
Series ASep 17, 2012
Amount Raised: $4,000,000